Clinical Trial Update: Persistent Atrial Fibrillation (AF) APAC (Asia Pacific) Observational Study

View source ↗

Summary

An Asia-Pacific observational study on persistent atrial fibrillation sponsored by Abbott Medical Devices has terminated with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Persistent Atrial Fibrillation | Status: TERMINATED | Results posted: 2024-04-19